Efficacy and safety of damage control in experimental animal models of injury: protocol for a systematic review and meta-analysis by unknown
Cosic et al. Systematic Reviews 2014, 3:136
http://www.systematicreviewsjournal.com/content/3/1/136PROTOCOL Open AccessEfficacy and safety of damage control in
experimental animal models of injury: protocol
for a systematic review and meta-analysis
Nela Cosic1†, Derek J Roberts1,2,3*† and Henry T Stelfox1,2,4Abstract
Background: Although abbreviated surgery with planned reoperation (damage control surgery) is now widely used
to manage major trauma patients, the procedure and its component interventions have not been evaluated in
randomized controlled trials (RCTs). While some have suggested the need for such trials, they are unlikely to be
conducted because of patient safety concerns. As animal studies may overcome several of the limitations of
existing observational damage control studies, the primary objective of this study is to evaluate the efficacy and
safety of damage control versus definitive surgery in experimental animal models of injury.
Methods/design: We will search electronic databases (Medline, Embase, PubMed, Web of Science, Scopus, and the
Cochrane Library), conference abstracts, personal files, and bibliographies of included articles. We will include RCTs
and prospective cohort studies that utilized an animal model of injury and compared damage control surgery (or
specific damage control interventions or adjuncts) to definitive surgery (or specific definitive surgical interventions).
Two investigators will independently evaluate the internal and external/construct validity of individual studies.
The primary outcome will be all-cause mortality. Secondary outcomes will include blood loss amounts; blood
pressures and heart rates; urinary outputs; core body temperatures; arterial lactate, pH, and base deficit/excess
values; prothrombin and partial thromboplastin times; international normalized ratios; and thromboelastography
(TEG) results/activated clotting times. We will calculate summary relative risks (RRs) of mortality and mean
differences (for continuous outcomes) using DerSimonian and Laird random effects models. Heterogeneity will be
explored using subgroup meta-analysis and meta-regression. We will assess for publication bias using funnel plots
and Begg’s and Egger’s tests. When evidence of publication bias exists, we will use the Duval and Tweedie trim
and fill method to estimate the potential influence of this bias on pooled summary estimates.
Discussion: This study will evaluate the efficacy and safety of damage control in experimental animal models of
injury. Study results will be used to guide future clinical evaluations of damage control surgery, determine which
animal study outcomes may potentially be generalizable to the clinical setting, and to provide guidelines to
strengthen the conduct and relevance of future pre-clinical studies.
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Hemorrhage is the leading preventable cause of death after
injury worldwide [1-4]. Thus, identifying evidence-based
methods of hemostasis is vitally important for improving
trauma patient outcomes [1,4]. However, while randomized
controlled trials (RCTs) have evaluated a range of medica-
tions and resuscitation strategies for bleeding trauma pa-
tients, few have reported improved patient outcomes [4,5].
As such, rapid and effective surgical or interventional
hemostasis remains the most effective treatment [6].
The conventional surgical approach to managing trau-
matic hemorrhage is to definitively repair all injured
organs in one operation [7]. However, as these repairs
often require a significant amount of time, ongoing blood
loss during surgery frequently leads to an inadequate
blood supply to peripheral tissues resulting in anaerobic
metabolism, lactic acidosis (low blood pH due to an accu-
mulation of arterial lactate), and a decline in core body
temperature [8,9]. Replacement of blood losses with crys-
talloid solutions devoid of clotting factors and platelets
also often produces or worsens coagulopathy (i.e., abnor-
mal blood clotting), which manifests as an absence of vis-
ible blood clots during surgery and/or abnormal clotting
test results [7-9].
Trauma patients who are bleeding heavily therefore
often develop a ‘lethal triad’ of hypothermia, acidosis,
and coagulopathy, which has been linked with a high
risk of mortality [7-10]. In order to shorten the duration
of surgery and prevent death in those with coagulopathy,
Stone et al. proposed abbreviated laparotomy with planned
reoperation (later termed damage control laparotomy in
1993) [7,11,12]. Instead of attempting to repair all injuries
during the index operation, this approach utilizes several
abbreviated (or damage control) interventions [7,11,12].
These include application of compressive gauze packs to
bleeding surfaces, tamponade of injured vascular structures
with balloons (i.e., balloon catheter tamponade), and use of
temporary intravascular shunts to bridge transected arter-
ies and veins [6-9]. It also includes interventions that rap-
idly control spillage from wounds of the gastrointestinal
organs, pancreas, and biliary tract [6,9].
As damage control laparotomy was associated with an
increase in unexpected survivors during a time that the
incidence of high energy and multicavitary penetrating
and blunt trauma was rising in the United States and
other countries, surgeons rapidly adopted this method
over definitive laparotomy for management of severely
injured patients [6,8]. The adoption of the procedure was
further accelerated by the publication of several cohort
studies, which reported that damage control surgery was
associated with reduced mortality when appropriately
applied [12-16]. As such, the procedure is now frequently
utilized worldwide for management of major trauma
patients [7].Despite its potential advantages, damage control lapar-
otomy is associated with several potentially severe com-
plications, reduced quality of life, and significant costs to
the health-care system [17-19]. Common complications
include intra-abdominal abscesses and sepsis [17-19].
Approximately 8–29% of patients must also be managed
with a ‘planned ventral hernia’ (in which the granulated
abdominal viscera are covered only with a skin graft,
resulting in a large hernia in the anterior part of the abdo-
men) [20-22]. Finally, there is an approximately 5% associ-
ated risk of development of enteroatmospheric fistulae, in
which one or more intestinal segments communicate with
the atmosphere, leading to significant patient distress,
poor hygiene, ongoing intra-abdominal infection, and dif-
ficulty with nutrition and wound management [17-19].
As a result of the perceived lack of clinical equipoise
among the surgical community, damage control has not
been compared to definitive surgery in a RCT [7]. Al-
though a recent Cochrane review suggested the need for
such a trial, this is unlikely to be conducted due to pa-
tient safety concerns and the challenges associated with
conducting a RCT of an emergent trauma surgical pro-
cedure [7,10]. Of the limited number of observational
studies that have now directly compared the effective-
ness of damage control and definitive surgery, the major-
ity are small, potentially underpowered, and often based
on retrospective reviews of databases maintained at sin-
gle centers [7,10,23-26]. Further, results of these studies
are frequently difficult to interpret due to varying inclu-
sion/exclusion criteria, the lack of a complete description
of which set of abbreviated trauma surgical procedures
was studied, and the unavoidable presence of confounding
by indication (whereby obvious or subtle differences exist
in the characteristics of patients who are selected for dam-
age control versus definitive surgery). Common baseline
confounding variables in damage control effectiveness
studies include the volume of resuscitation fluid provided
and presenting blood pressures, core body temperatures,
and acid/base and blood clotting measurements.
Study rationale and objective
Animal models have the potential to avoid the limitations
associated with retrospective reviews of human experiences
through the use of stringent inclusion/exclusion criteria,
standardized applications of interventions, randomization
of animals to treatment groups, allocation concealment,
and blinded assessments of outcome [27]. These types of
studies may also be used to provide a biological foundation
for surgical procedures [28,29]. Thus, the efficacy and
safety of damage control may potentially be able to be in-
formed by research conducted in animals [30-40].
In support of this, a large number of animal studies
have evaluated the efficacy of damage control surgery
and specific damage control interventions (e.g., rapid
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inal balloon occlusion of the aorta [33,42], and tempor-
ary intravascular shunting of the superior mesenteric
artery [30,39,40]) or adjuncts (e.g., commercial topical
hemostatic agents for massively bleeding groin injuries
[37,43]). See Table 1 for a complete list of damage con-
trol interventions/adjuncts that are currently used in
clinical practice, including a sample of those that have
been evaluated in animal models [30-32,39-41,43-53].
These studies may collectively provide insight into
which interventions have the most promise for further
clinical evaluation and use [27,29,54]. They may also re-
duce unwarranted animal use in future scientific studies
and allow for the development of guidelines to strengthen
the conduct and translational relevance of future pre-
clinical trials [28,55].
Although the above animal studies likely have many
advantages over currently published human studies, sev-
eral potential biases must be critically examined before
their results are attempted to be used to inform clinical
research and practice [27,28,55,56]. These include those
relating to construct validity, study design (e.g., sample
size determination, randomization, and allocation conceal-
ment), and publication bias [55,57,58]. For the results of
an animal study to potentially be translated to the clinical
environment, the model must have construct validity (i.e.,
it must mimic the realities of human injury care) [55,57].
For example, animals with a major vascular injury should
present with significant hemodynamic instability and ab-
normal physiology (e.g., hypothermia, acidosis, and/or co-
agulopathy). Further, interventions should be applied in a
somewhat delayed, instead of immediate, fashion (in order
to emulate the requisite time delays associated with trans-
port of injured patients to a trauma center and prepar-




Interventions Thoracic Therapeutic mediastinal
tractotomy, peripheral w
and rapid stapled pneum
Abdominal Perihepatic or diffuse in
segment of bowel with
techniques to control g
[6]; temporary abdomin
use of the Bogota bag [
Pelvis Extraperitoneal pelvic pa
Vascular Temporary intravascular
[9]; and arterial clampin





based dressings [43]; sel
balloon occlusion of thetheir analyses on sample size calculations, which provide
assurance that animals have not been added to a study
incrementally in response to interim analyses, and
intention-to-treat principles [55,58,61]. Finally, as signifi-
cant and positive results of animal studies are more likely
to be published (and to be published in English-language
journals), all of the available literature must be identified,
regardless of language or origin of publication, and the
potential influence of publication bias must be thoroughly
assessed [55].
The objective of the proposed systematic review and
meta-analysis is to compare the efficacy and safety of
damage control surgery (or specific damage control in-
terventions or adjuncts) to definitive surgery (or specific
definitive surgical interventions) in experimental animal
models of injury. We will also evaluate whether estimates
of efficacy vary with the construct validity of the model
and various study-level characteristics. In the presence of
publication bias, we will use the Duval and Tweedie trim
and fill method to determine the potential effect of adding
a cohort of theoretically unpublished studies to summary
estimates of efficacy.Methods/design
Protocol
This protocol was created according to the Preferred
Reporting Items in Systematic Reviews and Meta-analyses
statement [62], the Meta-Analyses of Observational Studies
in Epidemiology proposal [63], and the recommendations
for reporting of systematic reviews and meta-analyses of
animal experiments by Peters et al. [64] and Sena et al.
[55]. As protocols for systematic reviews of animal studies
are not currently eligible for inclusion in PROSPERO, this
protocol has not been registered.and/or pleural space packing [6]; rapid lung-sparing surgery (pulmonary
edge resection, or pneumonorraphy) [7]; pulmonary hilum twisting [6];
onectomy
tra-abdominal packing [7]; peripancreatic drainage [7]; resection of a
delayed reanastomosis [7,8], rapid bowel ligation [31,41], or other
astrointestinal spillage, including the use of skin staplers or allis clamps
al closure techniques (including negative pressure peritoneal therapy or
32]); and intraintestinal drainage
cking [7]
shunting [30,39,40]; vascular ligation [30]; balloon catheter tamponade
g [53]
ts, including combat gauze or a fibrin patch [6,49,50] and modified
stat bandage [44]; powders containing fibrin, collagen, and/or thrombin
ssings [45]; absorbable mesh wraps/bandages [51,52]; zeolite powder-
f-expanding, intracavitary polyurethane polymers [46]; and resuscitative
aorta (REBOA) [47].
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Primary question
Is damage control surgery (or a specific damage control
intervention) more efficacious in reducing mortality than
definitive surgery (or a specific definitive surgical inter-
vention) in experimental mammalian models of injury?
Secondary questions
1) Are particular damage control interventions (e.g.,
balloon catheter tamponade) more efficacious in
reducing mortality than other damage control
interventions in experimental mammalian models
of injury?
2) Are particular damage control adjuncts (e.g., topical
hemostatic agents) more efficacious in reducing
mortality than use of no damage control adjunct or
other damage control adjuncts in experimental
mammalian models of injury?
Search strategy
We will modify a sensitive search strategy previously de-
veloped for use in identifying studies of damage control
surgery and damage control interventions [7]. With as-
sistance from a medical librarian/information-scientist,
we will search Ovid Medline and Embase, PubMed, Web
of Science, Scopus, and the Cochrane Library without
language, publication date, or other restrictions (Table 2
provides details of our planned bibliographic database
search strategies). In order to increase the sensitivity of the
search, we will also review the reference lists of all included
and relevant review articles identified during the conduct
of the search and use the PubMed ‘related articles’ and
Google Scholar ‘cited by’ features. To identify studies that
are about to be published, we will contact trauma surgery
experts and relevant researchers in the field and conduct
manual searches of abstracts for conferences held between
2009–2013, including meetings of the American Associ-
ation for the Surgery of Trauma, American College of
Surgeons, Eastern Association for the Surgery of Trauma,
International Association for Trauma Surgery and Inten-
sive Care, Trauma Association of Canada, and the Western
Trauma Association [7].
Study selection
Two investigators (N.C., D.J.R.) will independently screen
the titles and abstracts of all citations identified by the
search and select those that may have involved animals
and which mention use of damage control surgery, inter-
ventions, or adjuncts for full-text review. We will include
studies: 1) that involved large (sheep, swine, and non-
human primates, among others) or small (mice, rats, dogs,
and cats, among others) animals in which injury was in-
duced in vivo surgically or through an external blunt orpenetrating force; 2) where the experimental intervention
was damage control surgery, a damage control interven-
tion, or a damage control adjunct; 3) where the com-
parator intervention was definitive surgery, a definitive
surgical procedure, or an alternate type of damage con-
trol intervention or adjunct (or no damage control
adjunct); and 4) where the study design was a RCT or
prospective cohort study. Both RCTs and prospective
cohort studies will be included as many potentially
confounding factors are frequently controlled for in
non-randomized animal studies. Injuries of interest will
include those resulting in solid, hollow, and/or vascular
organ damage in the trunk (neck, thorax, abdomen, or
pelvis) as well as extremity vascular trauma [7,9]. For
the purpose of this study, damage control surgery will
be defined as ‘a multi-step operative intervention, which
includes an abbreviated initial surgical procedure (or set
of procedures) that aims to control obvious mechanical
bleeding or contamination as compared to definitively
repairing all injuries’ [7]. Definitive surgery will be defined
as complete repair of the injury/injuries of interest at the
index operation followed by formal closure of the explored
cavity or region. In order to be as sensitive as possible, we
will not predefine damage control interventions or dam-
age control adjuncts. Instead, damage control interven-
tions and adjuncts will be defined by study authors.
Agreement between investigators regarding identifica-
tion of abstracts for full-text review and inclusion of
articles in the systematic review will be quantified using
kappa statistics [65]. Disagreements will be resolved by
consensus between the two investigators.
Primary outcome
The primary outcome will be all-cause mortality mea-
sured at the longest follow-up time after administration
of the intervention.
Secondary outcomes
Secondary outcomes will include volumes and/or rates
of blood loss; laboratory surrogates of blood loss
(complete blood counts, hemoglobin concentrations,
and/or hematocrit values); and physiologic measure-
ments, including blood pressures (mean arterial [MAP],
systolic, and diastolic), heart rates, urinary outputs, core
body temperatures, arterial lactate, base deficit/excess,
and pH values, prothrombin and partial thromboplastin
times, international normalized ratios, and thromboe-
lastography (TEG) results/activated clotting times.
Data extraction
Two investigators (N.C., D.J.R.) will independently ex-
tract data from included studies using a pre-designed
data extraction spreadsheet. The design and reliability of
the spreadsheet will be pilot tested on a random sample
Table 2 Details of electronic bibliographic database search strategies
Ovid Medline and Medline In Process and Other Non-indexed
Citations, PubMed, and the Cochrane Library
Ovid Embase
1. damage control.ab,ti. 1. damage control.ab,ti.
2. (damage control adj3 (surg* or procedure* or approach* or
laparotom* or celiotom*or thoracotom*)).ab,ti.
2. (damage control adj3 (surg* or procedure* or approach* or
laparotom* or celiotom* or thoracotom*)).ab,ti.
3. (abbreviated adj3 (surg* or procedure* or laparotom* or celiotom*
or thoracotom*)).ab,ti
3. (abbreviated adj3 (surg* or procedure* or laparotom* or celiotom*
or thoracotom*)).ab,ti.
4. (staged adj3 (surg* or procedure* or approach* or laparotom*
or celiotom* or thoracotom*)).ab,ti.
4. (staged adj3 (surg* or procedure* or approach* or laparotom* or
celiotom* or thoracotom*)).ab,ti.
5. (bailout adj3 (surg* or laparotom* or celiotom* or
thoracotom*)).ab,ti.
5. (bailout adj3 (surg* or laparotom* or celiotom* or
thoracotom*)).ab,ti.
6. ((abdom* or thora* or chest* or liver* or hepatic) adj5 pack*).ab,ti. 6. ((abdom* or thora* or chest* or liver* or hepatic) adj5 pack*).ab,ti.
7. (balloon adj3 (tamponade or catheter tamponade)).ab,ti. 7. (balloon adj3 (tamponade or catheter tamponade)).ab,ti.
8. (temporary intravascular shunt* or intravascular shunt* or vascular
shunt* or arterial shunt* or artery shunt*).ab,ti.
8. (temporary intravascular shunt* or intravascular shunt* or vascular
shunt* or arterial shunt* or artery shunt*).ab,ti.
9. (topical hemostatic agent or combat gauze or fibrin patch or
modified rapid deployment hemostat bandage)
9. (topical hemostatic agent or combat gauze or fibrin patch or
modified rapid deployment hemostat bandage)
10. (fibrin or collagen or thrombin or zeolite or chitosan) adj3
(powder* or dressing*)
10. (fibrin or collagen or thrombin or zeolite or chitosan) adj3
(powder* or dressing*)
11. (intracavitary polyurethane polymer* or REBOA or resuscitative
balloon occlusion)
11. (intracavitary polyurethane polymer* or REBOA or resuscitative
balloon occlusion)
12. exp ‘Wounds and Injuries’/ 12. exp injury/
13. exp Multiple Trauma/ 13. exp blunt trauma/
14. exp Wounds, Penetrating/ 14. exp multiple trauma/
15. exp Wounds, Gunshot/ 15. exp stab wound/
16. exp Wounds, Stab/ 16. exp missile wound/
17. exp Wounds, Nonpenetrating/ 17. exp abdominal injury
18. exp Abdominal Injuries/ 18. exp thorax injury/
19. exp Thoracic Injuries/ 19. exp bleeding/
20. exp Hemorrhage/ 20. (trauma* or multiple trauma* or polytrauma or penetrating
trauma* or penetrating injur* or blunt trauma* or blunt injur*
or injur* or wound* or stab* or gunshot*).ab,ti.
21. (trauma* or multiple trauma* or polytrauma or penetrating
trauma* or penetrating injur* or blunt trauma* or blunt injur*
or injur* or wound* or stab* or gunshot*).ab,ti.
21. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11
22. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 22. 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20
23. 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 23. 21 and 22
24. 22 and 23
Table and search strategy modified from Roberts et al. [7]. ‘Where ab,ti. refers to abstract and title; exp to an exploded Medical Subject Heading term search; and
adjX to an adjacency operator that will search for terms within X words of the key term of interest. The “*” indicates that a wildcard search will be performed: for
example, in the case of surg*, surgery, surgical, and surgeries, among others, would all be searched for’ [7].
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ies until it is clear that the form captures all relevant infor-
mation and consistency in data extraction is achieved
(κ statistic ≥0.75) [65]. If a non-English language article
appears potentially relevant (or if it is unclear if it is rele-
vant), a single interpreter alone will review this article in
full and complete data extraction if it satisfies inclusion/
exclusion criteria. We will extract data from included
studies on: 1) study characteristics; 2) characteristics of
the included animals and the animal model, including the
nature of the induced injury; 3) the treatment that wasemployed; and 4) mortality and secondary outcome mea-
sures (see Table 3 for a detailed description of the data to
be collected) [66]. A RCT will be distinguished from a
prospective cohort study using the criteria suggested by
Oleckno [67].
Risk of bias assessment
Two investigators (N.C., D.J.R.) will independently assess
the internal and external/construct validity of included
studies. Internal validity will be evaluated using a modi-
fied version of the ten-item Collaborative Approach to
Table 3 Relevant data extraction information
Data extraction category Specific information to extract
Study characteristics Author(s); year of publication, study design (randomized controlled trial or prospective cohort).
Characteristics of animal model Species; strain; gender; total number of animals; number of animals in each experimental cohort;
number of animals excluded; age (in total and per experimental cohort); weight (in total and per
experimental cohort); and physiological characteristics reported by the authors at baseline before
application of interventions (in total and per experimental cohort).
Details of injury induced in animals Specifics of the injury that was induced; mechanism of producing the injury model (as described by
authors); anatomical location of the injury or injuries (e.g., polytrauma model vs. single/more localized
type of injury); and injury severity (e.g., specific grade of liver injury).
Details of treatment employed Whether an entire damage control paradigm or an individual intervention or adjunct was tested; the
specific treatment that was evaluated; and the definition of damage control surgery. Additional details
collected are based on a modified version of the elements of experimental procedures outlined in the
Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines: how, when, where, and why [66]:
How? Specific method of employment of treatment tested and how long it was applied for. When?
How long after injury was induced was the intervention(s)/adjunct(s) implemented? Where? Laboratory
setting, surgical theater, or alternate setting as described by author(s). Why? To evaluate the purpose of
testing the treatment.
Consequences of damage control surgery
and/or definitive surgery to animals
Mortality; changes in post-injury physiological parameters, including estimated volumes and/or rates of
blood loss, laboratory surrogates of blood loss (complete blood counts, hemoglobin concentrations,
and/or hematocrits); and several physiologic measurements, including blood pressures (mean arterial
(MAP), systolic, and diastolic), heart rates, urinary outputs, and core body temperatures, and arterial
lactate, base deficit/excess, and pH values, prothrombin and partial thromboplastin times, international
normalized ratios, and thromboelastography (TEG) results/activated clotting times.
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mental Studies (CAMARADES) checklist, which as-
sesses the risk of study design-related biases in animal
studies [57,62,68] (see below for a modified list of the
CAMARADES checklist items to be assessed). A modi-
fied version of the Studies of Translation, Ethics, and
Medicine (STREAM) checklist with additional factors
incorporated from Lamontagne et al. and Krauth et al.
will be utilized to evaluate construct validity [55,59,62,69]
(see below for a modified list of the STREAM elements of
interest to be assessed). The STREAM checklist is a tool
designed to assess the internal, external, and construct val-
idity of pre-clinical studies to determine their potential to
be used to inform the design of clinical trials [55,69]. To
further evaluate external validity, we will assess whether
the same conclusions were found in different studies
that induced the same injury model and employed the
same treatment in different types of animals (species or
strain) [55,69].
Modified CAMARADES checklist items for assessing
internal validity of individual studies [56,61]
▪ Publication in a peer-reviewed journal instead of only
in abstract form
▪ Randomization of treatment
▪ Presence of allocation concealment
▪ Blinded assessment of outcome
▪ Conduct of a pre-experimentation sample size
calculation
▪ Evidence of animal welfare compliance
▪ Statement regarding possible conflict of interest▪ Completeness of follow-up
The checklist items ‘statement of control of temperature’
and ‘use of animals with hypertension or diabetes’ were re-
moved from the above list as they were developed for
assessing animal studies of stroke interventions [56,67].
The item ‘avoidance of anesthetic with marked intrinsic
properties’ was also removed as it will be addressed in the
assessment of construct validity [54,56,69]. The item ‘com-
pleteness of follow-up’ was added to the list as per guide-
lines proposed by Lamontagne et al. [61].
Modified STREAM checklist items for assessing construct
validity of individual studies [56,58,61,69]
▪ The extent that the injury induced in the animal
model accurately represents the realities of the injury
in humans
▪ The extent that the intrinsic characteristics of the
animals chosen represent the civilian population that
is most likely to receive damage control
▪ Relevance of treatment tested to the clinical setting
▪ Evaluation of whether treatments were employed
accurately/as they would in the clinical setting
▪ Explicit statement that an intention-to-treat analysis
was used
▪ Explicit statement of inclusion reason(s) for animals
utilized in study
▪ Explicit statement of exclusion reason(s) for animals
removed from analysis of results
▪ Explicit statement in study addressing potential
confounding factors/sources of bias
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emulate realities of emergent surgical care
▪ Evidence of a pre-specified stopping rule
▪ Reporting of a potentially patient-important outcome
such as mortality
The clinical relevance of the study design will be assessed
independently by two fellowship-trained trauma surgeons.
For the item related to providing evidence of delay in em-
ployment of treatment, if the intervention was applied in
the ambulance, the delay should be approximately 20 min
to account for a 5-min response time and about a 15-min
on scene time [60]; if the intervention was applied in
the Emergency Department, the delay should be ap-
proximately 30 min [59,60]; and if the intervention was
applied in the operating room, the delay should be ap-
proximately 45 min [59].
Data synthesis
Both a narrative synthesis and, where possible, a meta-
analysis of the results of the individual studies will be
presented. Studies will first be grouped according to the
types of interventions and controls studied. After studies
have been combined into common groups, their character-
istics will be presented in summary tables. These groupings
will be utilized to determine where categories of studies
exist that have similar enough designs to allow for a meta-
analysis of their reported outcomes.
Statistical analyses
To address the primary research question, we will calcu-
late individual study estimates of the relative risk (RR)
comparing mortality between animals that received dam-
age control (or a specific damage control intervention)
versus definitive surgery (or a definitive surgical interven-
tion). Similarly, for the secondary research questions, we
will calculate RRs comparing mortality between animals
that received different damage control interventions or ad-
juncts or a damage control adjunct versus no adjunct. As
we expect that there will be ‘clinical’ heterogeneity in the
design and/or conduct of the included studies, individual
study RR estimates will be combined using DerSimonian
and Laird random effects models [70]. However, in the
event that we find little clinical heterogeneity between
studies, we will combine individual study RR estimates
using fixed effect models with Mantel-Haenszel weighting
[71]. Where possible, for both the primary and secondary
research questions, we will also use random effects or
fixed effect models and the reported within-group mean
values to calculate summary mean differences for the
above secondary outcome variables.
We will examine for evidence of between-study het-
erogeneity by calculating I2 inconsistency values and
conducting Cochran’s Q hypothesis tests of homogeneity(p value <0.1 considered significant given the low power
of these tests). Heterogeneity will be defined according
to the value of the I2 statistic as low (I2 > 25%), moderate
(I2 > 50%), and high (I2 > 75%) [72]. In the presence of
heterogeneity, we will conduct stratified meta-analyses
and meta-regression to determine whether our summary
estimates vary across different study-level covariates.
Covariates of interest will include characteristics of study
internal validity, including whether randomization of an-
imals to treatment was performed, allocation was con-
cealed, or a sample size calculation was reported to have
been done [57]. Other covariates will include character-
istics of external/construct validity, including whether an
intention-to-treat analysis was used, whether potential
confounding factors were well balanced between the
groups at baseline or controlled for, or whether there
was a delay in employment of the treatment of interest
by at least 30 min for an intervention designed to be ap-
plied in the Emergency Department versus 45 min for one
designed to be used in the operating room [55,59,62,69].
Important confounding variables that should have been
considered by study authors include baseline blood pres-
sures, core body temperatures, arterial pH values, and la-
boratory clotting test results.
We will assess for the presence of small study effects
potentially due to publication bias by plotting funnel
plots of the RR of mortality. Evidence for the existence
of funnel plot asymmetry will be assessed using Begg’s
funnel plot asymmetry test and confirmed using Egger’s
regression test [73,74]. When evidence of publication
bias exists, we will use the Duval and Tweedie ‘trim and
fill’ method to estimate the potential influence of this
bias on our pooled summary estimates [75,76]. In this
method, the small outlying study results are first ‘trimmed’
(removed until the funnel plot appears symmetrical) and
then the remaining symmetric study results are used to
re-estimate the ‘true’ center of the plot [75-77]. Subse-
quently, the plot is ‘filled’ (the missing outlying study
results and their theoretical ‘counterparts’ are replaced
around the re-estimated center) and an adjusted pooled
estimate is calculated [75-77].
Discussion
Animal experiments are frequently used to evaluate inter-
ventions before they are used clinically. Although animal
studies provide evidence of the performance of interven-
tions under relatively ideal conditions, some are limited by
study design-related biases and/or a lack of model con-
struct validity. Thus, systematic reviews of these types of
studies may be used to outline which interventions tested
in animal models do not yet have enough supporting evi-
dence to warrant evaluation in clinical trials [29,55-57,78].
Unfortunately, it has been reported that this may infre-
quently occur in practice. For example, in a systematic
Cosic et al. Systematic Reviews 2014, 3:136 Page 8 of 10
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mic stroke, the drugs that were ultimately evaluated clinic-
ally were no more effective in animal models than those
not evaluated clinically [78].
Systematic reviews of animal intervention studies are
therefore important to guide the transition of scientific
findings from the bench to the bedside [78]. These re-
views may be used to determine that interventions with
consistent positive outcomes across several experimental
studies may safely be generalized to the design and conduct
of clinical trials [29,30,55,79]. For example, a systematic
review of the effect of hypothermia in acute ischemic stroke
demonstrated that infarct size was consistently reduced
across all animal models when core body temperature was
cooled to approximately 35°C [79]. There have since been
multiple clinical trials (with many still in progress) evaluat-
ing the effect of cooling in acute ischemic stroke patients,
including the Nordic Cooling Stroke Study (NOCSS) and
the Cooling in Acute Stroke-II (COAST-II) study [80,81].
Systematic reviews of animal studies have also influ-
enced the conduct of pre-clinical trials. Several system-
atic reviews have suggested how the design, construct
validity, methodological rigor, and reporting of animal
studies may be improved such that their relevance to hu-
man healthcare is enhanced [56,57,82]. In addition, the
compilation of world literature regarding pre-clinical ani-
mal models outlines which studies have already been con-
ducted in animals, thereby potentially preventing wasteful
allocation of future resources to studies that will be inef-
fective or repetitive (and protecting animals from poten-
tially unwarranted future experimentation) [30].
Through this systematic review and meta-analysis, we
seek to establish whether damage control is more effica-
cious than definitive surgery and if so, which damage
control interventions are more efficacious than others.
To accomplish this, we will assemble all original scientific
research examining the efficacy and safety of damage con-
trol in experimental animal models of injury. After consid-
ering animal model construct validity, study design-related
biases, and whether publication bias may have existed, we
will determine which damage control interventions or
adjuncts may potentially provide valid and generalizable
evidence for further clinical evaluation and suggest how
to improve future pre-clinical trials. Thus, our results
may be used to both inform clinical research and prac-
tice and more appropriately direct future research con-
ducted in animals.Abbreviations
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